Compare SMG & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMG | LQDA |
|---|---|---|
| Founded | 1868 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.1B |
| IPO Year | N/A | 2018 |
| Metric | SMG | LQDA |
|---|---|---|
| Price | $58.48 | $34.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $69.50 | $37.40 |
| AVG Volume (30 Days) | 797.2K | ★ 1.1M |
| Earning Date | 01-28-2026 | 11-03-2025 |
| Dividend Yield | ★ 4.52% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.47 | N/A |
| Revenue | ★ $3,413,100,000.00 | $69,216,000.00 |
| Revenue This Year | $1.34 | $994.17 |
| Revenue Next Year | $2.23 | $169.25 |
| P/E Ratio | $23.62 | ★ N/A |
| Revenue Growth | N/A | ★ 343.41 |
| 52 Week Low | $45.61 | $11.26 |
| 52 Week High | $79.12 | $36.41 |
| Indicator | SMG | LQDA |
|---|---|---|
| Relative Strength Index (RSI) | 57.68 | 57.39 |
| Support Level | $57.07 | $33.45 |
| Resistance Level | $59.80 | $36.60 |
| Average True Range (ATR) | 1.51 | 1.34 |
| MACD | 0.05 | -0.26 |
| Stochastic Oscillator | 66.40 | 59.91 |
Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The business consists of three reporting segments: US consumer, Hawthorne, and other. The US consumer segment consists of a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Hawthorne sells indoor gardening and hydroponic equipment, particularly to the cannabis growing industry, while the other segment primarily consists of lawn and gardening products sold in Canada. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.